赛诺菲的喜保宁多少钱一盒？一盒多少粒？

The generic name vigabatrin, brand name Sabril, is a drug used to treat epilepsy and infantile spasms. It was developed in the 1980s. The treatment was approved in the UK in 1989.

On August 21, 2009, the U.S. FDA approved Sabril as a monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjunctive (additional) treatment for adult patients with refractory complex partial epilepsy (CPS).

On January 16, 2019, the FDA approved the launch of a generic version of Sabril (vigabatrin). Vigabatrin is sold under the brand name Sabril in Canada, Mexico, and the United Kingdom. The Danish brand name is Sabrilex.

At present, there is no unified standard for the specific application dosage and application time of Vigabatrin. The dosage reported in the literature is 18C200 mg/kg/day [25]. The starting dose recommended by the American TSC consensus [148-150] is 50 mg/kg/day, and then gradually increased to 100C150 mg/kg/day based on the child's response to the drug.

How much does a box of Sanofi cost? How many pills per box? Currently, more patients are keen on Sanofi's Vigabatrin on the market. Sanofi (NYSE: SNY) was founded in 1973. Its predecessor was Sanofi-Aventis. It was changed to its current name: Sanofi in May 2011. It is headquartered in Paris, France, and has 113,496 full-time employees in more than 100 countries around the world. It is the world's leading diversified pharmaceutical and health company with diversified products, including drugs, vaccines and innovative treatment solutions. According to Medical Companion Travel, the specification of Sanofi Vigabatrin is 500mg*100 capsules/box, and the price is equivalent to RMB 1,450. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Vigabatrin, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.